<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001409751</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0000075252</issuerCik>
<issuerName>Accendra Health, Inc.</issuerName>
<secFileNumber>001-09810</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">4435 Waterfront Drive</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Suite 300</street2>
<city xmlns="http://www.sec.gov/edgar/common">Glen Allen</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">VA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">23060</zipCode>
</issuerAddress>
<issuerContactPhone>804-277-4304</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Coliseum Capital Management, LLC</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>  10% Stockholder					</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>JonesTrading Institutional Services LLC</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">555 Saint Charles Drive</street1>
<city xmlns="http://www.sec.gov/edgar/common">Thousand Oaks</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">91360</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>10726759</noOfUnitsSold>
<aggregateMarketValue>11584899.72</aggregateMarketValue>
<noOfUnitsOutstanding>76904704</noOfUnitsOutstanding>
<approxSaleDate>09/11/2026</approxSaleDate>
<securitiesExchangeName>NYSE</securitiesExchangeName>
</securitiesInformation>
<securitiesInformation>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Virtu Americas LLC</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">1633 Broadway</street1>
<city xmlns="http://www.sec.gov/edgar/common">New York</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">10019</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>10726759</noOfUnitsSold>
<aggregateMarketValue>11584899.72</aggregateMarketValue>
<noOfUnitsOutstanding>76904704</noOfUnitsOutstanding>
<approxSaleDate>09/11/2026</approxSaleDate>
<securitiesExchangeName>NYSE</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>07/31/2024</acquiredDate>
<natureOfAcquisitionTransaction>Open Market Purchases. Please refer to explanatory notes under "Remarks" below.</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Open Market Purchases.  Please refer to explanatory notes under "Remarks" below.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>10726759</amountOfSecuritiesAcquired>
<paymentDate>07/31/2024</paymentDate>
<natureOfPayment>Cash</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<remarks>The securities referred to in this Form 144 are held directly by (a) Coliseum Capital Partners, L.P., an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser and (b) a separate account investment advisory client of CCM. Christopher Shackelton and Adam Gray are managers of and have an ownership interest in each of CCM and CC.
Regarding the "Securities To Be Sold" table, the dates of acquisition and dates of payment varied, with purchases commencing on July 31, 2024 and ceasing on August 14, 2025.</remarks>
<noticeSignature>
<noticeDate>09/11/2026</noticeDate>
<signature>Chivonne Cassar, as Attorney-in-Fact</signature>
</noticeSignature>
</formData>
</edgarSubmission>
